Can-Fite BioPharma Ltd. Finance Costs
Can-Fite BioPharma Ltd. (CANF) reported Finance Costs of $693.00 thousand for the 12-month period ending 2019-12-31, per its 20-F filed 2020-03-27.
Discontinued › Expense Statement › Operating Expenses
ifrs-full:FinanceCosts · last filed 2020-03-27
| Period end | Finance Costs 6 month | Finance Costs 12 month | Finance Costs 12 month as first filed |
|---|---|---|---|
| 2019-12-31 | $693.00K 20-F · filed 2020-03-27 | ||
| 2019-06-30 | $324.00K 6-K · filed 2019-08-30 | ||
| 2018-12-31 | $1.20M 20-F · filed 2020-03-27 | ||
| 2018-06-30 | $346.00K 6-K · filed 2019-08-30 | ||
| 2017-12-31 | $621.00K 20-F · filed 2020-03-27 | $1.10M 20-F · filed 2018-03-28 | |
| 2017-06-30 | $305.00K 6-K · filed 2018-08-31 | ||
| 2016-12-31 | $55.00K 20-F · filed 2019-03-29 | -$55.00K 6-K · filed 2018-08-08 | |
| 2015-12-31 | -$133.00K 6-K · filed 2018-08-08 |